P&G's profit squeezed by tariffs and trade-down, but wellness bet and dividends offer support
Tariffs and commodity costs to cut profit by ~$1B P&G expects tariffs and higher commodity costs to reduce fiscal 2027 profit by about $1 billion, or $0.56 per share. This is a direct hit to earnings and a key reason guidance is cautious.
This is a major new cost headwind that directly pressures P&G's profit and stock price.
Consumers trading down to cheaper store brands Volumes remain flat as consumers switch to cheaper store-brand products. This weak demand limits P&G's ability to raise prices and grow sales, contributing to slower 1–3% organic growth guidance.
It explains the weak demand environment and why revenue missed estimates.
Buying Thorne for $3.8B to expand into wellness P&G is acquiring supplement maker Thorne for $3.8 billion, moving into the fast-growing wellness market. This diversification could open new revenue streams beyond traditional household products.
It shows a strategic move to offset weak core growth and enter a higher-growth category.
70-year dividend streak with ~$15B payouts planned P&G is extending its 70-year dividend streak with roughly $15 billion in planned fiscal 2027 payouts, offering a 2.9% yield near five-year highs. This income appeal supports the stock price.
It highlights a key attraction for investors and a support for the share price amid earnings pressure.
